循环肌钙蛋白浓度与老年人左室收缩及舒张功能及新发心衰的关联
该研究基于ARIC队列中4111名无心血管疾病的老年人,分析高敏肌钙蛋白T(hs-cTnT)与超声心动图左室收缩及舒张功能及新发心衰的关联。结果显示,hs-cTnT升高与左室质量指数增加及舒张功能恶化独立相关,但与收缩功能无关;舒张功能可解释hs-cTnT与新发射血分数保留心衰关联的41%。
要点
- hs-cTnT升高与左室质量指数增加及舒张功能恶化独立相关,与收缩功能无关。
- 舒张功能可解释hs-cTnT与射血分数保留心衰关联的41%。
- hs-cTnT升高与舒张功能障碍对心衰发生具有相加风险。
核心结论
- hs-cTnT浓度升高与更差的舒张功能相关,且独立于左室质量指数,但与收缩功能无关。
- 高水平的hs-cTnT可能作为亚临床舒张功能改变的早期标志,从而易感心衰。
研究设计与样本
- 基于ARIC前瞻性队列研究,纳入4111名无心血管疾病的参与者。
- 女性2586名(62.9%),平均(SD)年龄75(5)岁。
- hs-cTnT在访視5中位(IQR)浓度为9(7-14)ng/L,96.0%可检测到。
主要发现
- 校正人口学和临床协变量后,hs-cTnT较高与左室质量指数较大相关(第1组校正均值[SE] 33.8[0.5] vs 第5组40.1[0.4];趋势P<.001)。
- hs-cTnT较高与舒张功能较差相关:组织多普勒e'较低(6.00[0.07] vs 5.54[0.06];趋势P<.001),E/e'比值较高(11.4[0.2] vs 12.9[0.1];趋势P<.001),左房容积指数较大(23.4[0.4] vs 26.4[0.3];趋势P<.001),独立于左室质量指数。
- hs-cTnT水平与左室收缩功能指标无关。
- 校正舒张功能后,hs-cTnT与新发HFpEF的关联减弱41%,与射血分数中间值及降低心衰(LVEF<50%)合并的关联减弱17%。
- hs-cTnT升高与舒张功能障碍对心衰发生具有相加风险;从中年到晚年可检测到hs-cTnT的持续时间越长,晚年左室质量越大,但与收缩或舒张功能无关。
临床怎么用
- hs-cTnT可能作为早期识别亚临床舒张功能异常及心衰易感个体的标志物。
- 在老年人群中,评估hs-cTnT有助于判断舒张功能相关心衰风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cardiac troponin is associated with incident heart failure and greater left ventricular (LV) mass. Its association with LV systolic and diastolic functions is unclear. OBJECTIVES: To define the association of high-sensitivity cardiac troponin T (hs-cTnT) with LV systolic and diastolic functions in the general population, and to evaluate the extent to which that association accounts for the correlation between hs-cTnT concentration and incident heart failure overall, heart failure with preserved LV ejection fraction (LVEF; HFpEF), and heart failure with LVEF less than 50%. DESIGN, SETTING, AND PARTICIPANTS: This analysis of the Atherosclerosis Risk in Communities (ARIC) Study, an ongoing epidemiologic cohort study in US communities, included participants without cardiovascular disease (n = 4111). Available hs-cTnT measurements for participants who attended ARIC Study visits 2 (1990 to 1992), 4 (1996 to 1998), and 5 (2011 to 2013) were assessed cross-sectionally against echocardiographic measurements taken at visit 5 and against incident health failure after visit 5. Changes in hs-cTnT concentrations from visits 2 and 4 were also examined. Data analyses were performed from August 2017 to July 2018. MAIN OUTCOMES AND MEASURES: Cardiac structure and function by echocardiography at visit 5, and incident heart failure during a median 4½ years follow-up after visit 5. RESULTS: Of the 6538 eligible participants, 4111 (62.9%) without cardiovascular disease were included. Among these participants, 2586 (62.9%) were female, and the mean (SD) age was 75 (5) years. Median (interquartile range) hs-cTnT concentration at visit 5 was 9 (7-14) ng/L and was detectable in 3946 participants (96.0%). After adjustment for demographic and clinical covariates, higher hs-cTnT levels were associated with greater LV mass index (adjusted mean [SE] for group 1: 33.8 [0.5] vs group 5: 40.1 [0.4]; P for trend < .001) and with worse diastolic function, including lower tissue Doppler imaging e' (6.00 [0.07] vs 5.54 [0.06]; P for trend < .001), higher E/e' ratio (11.4 [0.2] vs 12.9 [0.1]; P for trend < .001), and greater left atrial volume index (23.4 [0.4] vs 26.4 [0.3]; P for trend < .001), independent of LV mass index; hs-cTnT level was not associated with measures of LV systolic function. Accounting for diastolic function attenuated the association of hs-cTnT concentration with incident HFpEF by 41% and the association with combined heart failure with midrange and reduced ejection fraction combined (LVEF <50) by 17%. Elevated hs-cTnT concentration and diastolic dysfunction were additive risk factors for incident heart failure. For any value of late-life hs-cTnT levels, longer duration of detectable hs-cTnT from midlife to late life was associated with greater LV mass in late life but not with worse LV systolic or diastolic function. CONCLUSIONS AND RELEVANCE: This study shows that higher hs-cTnT concentrations were associated with worse diastolic function, irrespective of LV mass, but not with systolic function; these findings suggest that high levels of hs-cTnT may serve as an early marker of subclinical alterations in diastolic function that may lead to a predisposition to heart failure.
引用
- Myhre PL, Claggett B, Ballantyne CM, et al. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults. JAMA Cardiol. 2019. PMID: 31483438. doi:10.1001/jamacardio.2019.3113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。